Statistical analysis showed that either in serum or in liver tissue, there was a significant upregulation of von Willebrand factor (vWF) in ASS HCC and downregulation of expression in the ASMq treatment group (P < 0.05) (Tables 4 and 5, Fig. 3). This evidence concerns the gene VWF and hepatocellular carcinoma.